AlzoSure Blood Test Will Achieve Earlier Alzheimer’s Treatments
The AlzoSure® Blood Test can catch Alzheimer’s two years before symptoms appear. Its development could not be more timely. With FDA approval of lecanemab for Alzheimer’s, this accurate and economical screening tool will dramatically assist patients most likely to benefit from early treatment.